C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/57 (2006.01) A61K 31/195 (2006.01) A61K 31/70 (2006.01) A61K 38/48 (2006.01) A61K 47/48 (2006.01) A61K 48/00 (2006.01) C07K 14/71 (2006.01) C12N 9/12 (2006.01) C12N 9/48 (2006.01) C12N 9/50 (2006.01)
Patent
CA 2196051
The invention provides a two component system for use in association with one another comprising: (a) a vector capable of expressing an enzyme at the surface of a cell; and (b) a prodrug which can be converted into an active drug by said enzyme, useful in the treatment of tumours.
Système à deux constituants destinés à être utilisés en association l'un avec l'autre, qui comprend (a) un vecteur capable d'exprimer une enzyme à la surface d'une cellule, et (b) un promédicament qui peut être converti en un médicament actif par ladite enzyme, utile dans le traitement des tumeurs.
Marais Richard
Springer Caroline Joy
Cancer Research Campaign Technology Limited
Mccarthy Tetrault Llp
LandOfFree
Surface expression of enzyme in gene directed prodrug therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Surface expression of enzyme in gene directed prodrug therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Surface expression of enzyme in gene directed prodrug therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1781880